Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Other financing activities (2022 - 2024)

Phibro Animal Health has reported Other financing activities over the past 3 years, most recently at $10.4 million for Q3 2024.

  • Quarterly results put Other financing activities at $10.4 million for Q3 2024, changed N/A from a year ago — trailing twelve months through Jun 2025 was $10.4 million (changed N/A YoY), and the annual figure for FY2025 was $10.4 million, changed.
  • Other financing activities for Q3 2024 was $10.4 million at Phibro Animal Health, up from $833000.0 in the prior quarter.
  • Over the last five years, Other financing activities for PAHC hit a ceiling of $10.4 million in Q3 2024 and a floor of $71000.0 in Q3 2022.
  • Median Other financing activities over the past 3 years was $701000.0 (2022), compared with a mean of $3.0 million.